🔎 Trials Near Me

Home › Kanser sa Prostate › Montana

Pag-aaral pangklinika para sa Kanser sa Prostate sa Montana

17 pag-aaral para sa Kanser sa Prostate ang naghahanap ng mga kalahok sa mga site sa Montana.

Mga Lungsod sa Montana

Opisyal na teksto ng pag-aaral (English)

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • Community Hospital of Anaconda, Anaconda
  • Billings Clinic Cancer Center, Billings
  • Bozeman Health Deaconess Hospital, Bozeman
  • at 3 pa
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT03866382

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

  • St. Vincent Frontier Cancer Center-Research ( Site 0037), Billings
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06136650

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

  • St. Vincent Frontier Cancer Center-Research ( Site 0037), Billings
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Set 17, 2026 · NCT06925737

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

  • Billings Clinic Cancer Center, Billings
  • Benefis Sletten Cancer Institute, Great Falls
  • Hi-Line Sletten Cancer Center, Havre
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Set 10, 2026 · NCT05946213

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

  • Community Hospital of Anaconda, Anaconda
  • Billings Clinic Cancer Center, Billings
  • Saint Vincent Frontier Cancer Center, Billings
  • at 4 pa
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Set 2, 2026 · NCT06931340

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

  • Billings Clinic Cancer Center, Billings
  • Bozeman Health Deaconess Hospital, Bozeman
  • Benefis Sletten Cancer Institute, Great Falls
  • at 1 pa
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Set 2, 2026 · NCT07200830

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Community Hospital of Anaconda, Anaconda
  • Billings Clinic Cancer Center, Billings
  • Bozeman Health Deaconess Hospital, Bozeman
  • at 7 pa
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT05334069

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

  • Billings Clinic Cancer Center, Billings
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT06632977

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

  • Billings Clinic Cancer Center, Billings
  • Bozeman Health Deaconess Hospital, Bozeman
  • Benefis Sletten Cancer Institute, Great Falls
  • at 5 pa
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Ago 19, 2026 · NCT04423211

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

  • Community Hospital of Anaconda, Anaconda
  • Billings Clinic Cancer Center, Billings
  • Bozeman Health Deaconess Hospital, Bozeman
  • at 7 pa
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Hul 14, 2026 · NCT06592924

Integrated Cancer Repository for Cancer Research

  • Bozeman Health Deaconess Hospital, Bozeman
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 19 hanggang 110 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT02012699

Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment

  • Billings Clinic Cancer Center, Billings
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Abr 14, 2026 · NCT06235697

Telehealth Exercise Program Evaluating Fatigue and Physical Function in Rural Cancer Survivors

  • University of Montana, Missoula
Nagre-recruitPhase 2
Edad 18 hanggang 89 · Lahat ng kasarian · Na-update Peb 5, 2026 · NCT07001241

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

  • Community Hospital of Anaconda, Anaconda
  • Billings Clinic Cancer Center, Billings
  • Bozeman Deaconess Hospital, Bozeman
  • at 4 pa
Nagre-recruitPhase 2
Edad 18 pataas · Kalalakihan · Na-update Ene 29, 2026 · NCT05806515

Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body

  • Community Hospital of Anaconda, Anaconda
  • Billings Clinic Cancer Center, Billings
  • Bozeman Health Deaconess Hospital, Bozeman
  • at 4 pa
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Ene 22, 2026 · NCT06470243

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Billings
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

  • Billings Clinic Cancer Center, Billings
  • Bozeman Deaconess Hospital, Bozeman
  • Saint James Community Hospital and Cancer Treatment Center, Butte
  • at 2 pa
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Set 11, 2025 · NCT03678025

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.